Avanir terminated about 11 percent of its sales force after CNN filed a report showing how the company paid 500 prescribers about $14M over three years for prescribers to tout…

There was a positive trend in the total group of patients but the difference did not reach statistical significance for this primary endpoint. Source: BioSpace

Five researchers were touted for their work in life sciences. Source: BioSpace

Tamid enters exclusive licensing deal with UNC-Chapel Hill for three preclinical gene therapy product candidates. Source: BioSpace

LifeOmic is planning to build new headquarters at the Indiana University Emerging Technology Center. Source: BioSpace

Pfizer is no stranger to taking the big gambles-note the company's attempts to buy Astra in 2014 and Allergan in 2016. Source: BioSpace

The patients who were transfusion dependent and switched from Soliris were forced to switch back to the Alexion drug. Source: BioSpace

The first $150 million is available immediately and an additional tranche of $50 million is available for draw by March 2019. Source: BioSpace

Rick Duprey, writing for The Motley Fool, takes a look at three biotech stocks that have quadrupled this year. Source: BioSpace

The Board of Directors also stated that it would endeavour to have a final clarification of the Company’s future by the end of 2017. Source: BioSpace